APA (7th ed.) Citation

Pettengell, R., Schmitz, N., Gisselbrecht, C., Smith, G., Patton, W. N., Metzner, B., . . . Goldstone, A. H. (2013). Rituximab purging and/or maintenance in patients undergoing autologous transplantation for relapsed follicular lymphoma: A prospective randomized trial from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Journal of clinical oncology, 31(13), . https://doi.org/10.1200/JCO.2012.47.1862

Chicago Style (17th ed.) Citation

Pettengell, Ruth, et al. "Rituximab Purging And/or Maintenance in Patients Undergoing Autologous Transplantation for Relapsed Follicular Lymphoma: A Prospective Randomized Trial from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation." Journal of Clinical Oncology 31, no. 13 (2013). https://doi.org/10.1200/JCO.2012.47.1862.

MLA (9th ed.) Citation

Pettengell, Ruth, et al. "Rituximab Purging And/or Maintenance in Patients Undergoing Autologous Transplantation for Relapsed Follicular Lymphoma: A Prospective Randomized Trial from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation." Journal of Clinical Oncology, vol. 31, no. 13, 2013, https://doi.org/10.1200/JCO.2012.47.1862.